Preliminary Outcomes for Treatment of High Intermediate- and High-risk Prostate Cancer Patients using Pelvic Intensity Modulated Radiotherapy with Hypofractionated Simultaneous Integrated Boost to Prostate

被引：2
|
作者：
Reddy, K. [1 ]
Nelson, B. C. [1 ]
McCammon, R. [2 ]
Rusthoven, K. E. [1 ]
Newman, F. [1 ]
Kavanagh, B. [1 ]
Raben, D. [1 ]
机构：
[1] Univ Colorado, Aurora, CO USA
[2] SE Radiat Oncol, Charlotte, NC USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.887
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S376 / S376
页数：1
相关论文
共 50 条
  • [41] A Treatment Planning Study of Moderately Hypofractionated Intensity-Modulated Proton Therapy (IMPT) to the Prostate and Pelvic Combined with Extremely Hypofractionated IMPT Boost to Prostate with Urethral Dose Reduction for High-Risk Prostate Cancer
    Liu, S.
    Gao, X.
    Ma, M.
    Zhao, Z.
    Qin, S.
    Zhao, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E782 - E782
  • [42] Late Toxicity in High-risk Prostate Cancer Treated with Androgen Suppression and Hypofractionated Intensity Modulated Radiotherapy
    Drodge, S.
    Pervez, N.
    Ghosh, S.
    Mackenzie, M.
    Yee, D.
    Mihai, A.
    Murtha, A.
    Amanie, J.
    Fallone, G.
    Pearcey, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S353 - S353
  • [43] IMRT pelvic radiotherapy with simultaneous integrated boost in high-risk prostate cancer: Results after 10 years.
    Ekanger, Christian
    Dahl, Olav
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] ACUTE TOXICITY IN HIGH-RISK PROSTATE CANCER PATIENTS TREATED WITH ANDROGEN SUPPRESSION AND HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY
    Pervez, Nadeem
    Small, Cormac
    MacKenzie, Marc
    Yee, Don
    Parliament, Matthew
    Ghosh, Sunita
    Mihai, Alina
    Amanie, John
    Murtha, Albert
    Field, Colin
    Murray, David
    Fallone, Gino
    Pearcey, Robert
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (01): : 57 - 64
  • [45] Intermediate- and High-Risk Prostate Cancer: A Plea for High-Dose, High-Precision Intensity-Modulated Radiotherapy With a Modulated Duration of Androgen Deprivation Therapy
    Bolla, Michel
    EUROPEAN UROLOGY, 2011, 60 (06) : 1140 - 1141
  • [46] Focal therapy in intermediate- and high-risk prostate cancer
    Huebner, Nicolai A.
    Korn, Stephan
    Rajwa, Pawel
    Shariat, Shahrokh F.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (04) : 247 - 250
  • [47] Focal therapy in intermediate- and high-risk prostate cancer
    Nicolai A. Huebner
    Stephan Korn
    Pawel Rajwa
    Shahrokh F. Shariat
    memo - Magazine of European Medical Oncology, 2023, 16 : 247 - 250
  • [48] Hypofractionated Simultaneous Integrated Boost IMRT in high risk prostate cancer - A novel approach
    Sashidharan, S.
    Beena, K.
    Chelakkot, P. G.
    Madhavan, R.
    Menon, D.
    Makuny, D.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S636 - S636
  • [49] Hypofractionated radiotherapy in high-risk prostate cancer using helical tomotherapy
    Pervez, N.
    Pearcey, R.
    Parliament, M.
    Yee, D.
    Amanie, J.
    Murtha, A.
    Pederson, J.
    Mihai, A.
    Mackenzie, M.
    Wachowicz, K.
    Fallone, G.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S94 - S94
  • [50] Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
    Wei Guo
    Yun-Chuan Sun
    Jian-Qiang Bi
    Xin-Ying He
    Li Xiao
    BMC Cancer, 19
12345